NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) announced today the launch of its pain research genotyping service by its Cogenics™ Division. Cogenics developed the proprietary genotyping service called the Pain Research Panel, which enables the investigation of key target genes involved in pain as well as those that mediate the therapeutic effects of pharmacological agents used to treat pain, inflammation, and mood conditions.
